India to Malaysia: Celecoxib Export Trade Route
India has recorded 157 verified shipments of Celecoxib exported to Malaysia, representing a combined trade value of $3.0M USD. This corridor is served by 18 active Indian exporters, with an average shipment value of $19.3K USD. The leading Indian exporter is MACLEODS PHARMACEUTICALS LTD , which accounts for 25% of total export value with 3 shipments worth $749.2K USD. On the buying side, DKSH MALAYSIA SDN BHD is the largest importer in Malaysia with $782.2K USD in purchases. The top 3 suppliers — MACLEODS PHARMACEUTICALS LTD , SHIFAA PHARMA, TORRENT PHARMACEUTICALS LTD — together control 56% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.

Route Intelligence Overview
The India to Malaysia Celecoxib corridor is one of India's established pharmaceutical export routes, with 157 shipments documented worth a combined $3.0M USD. The route is dominated by MACLEODS PHARMACEUTICALS LTD , which alone accounts for roughly 25% of all export value, reflecting the consolidated nature of India's celecoxib manufacturing sector.
Across 18 active suppliers, the average shipment value stands at $19.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (67%) and air (16%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during October–December, with an average transit time of 24 days port-to-port. The route has recorded an annual growth rate of 25.4%, placing it at rank #20 among India's top celecoxib export destinations globally.
On the import side, key buyers of Indian celecoxib in Malaysia include DKSH MALAYSIA SDN BHD, SYNERRY SDN BHD , EFS LOGISTICS SDN BHD, and 18 others. DKSH MALAYSIA SDN BHD is the single largest importer with 12 shipments valued at $782.2K USD.
Route Characteristics
- Average transit24 days
- Peak seasonQ4
- Primary modeMulti-modal
- Top portCHENNAI AIR CARGO ACC (INMAA4)
Market Position
- Global rank#20
- Annual growth+25.4%
- Demand growth+21.4%
- Regulatory ease67/100
Top 10 Indian Celecoxib Exporters to Malaysia
Showing top 10 of 18 Indian suppliers exporting Celecoxib to Malaysia, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | MACLEODS PHARMACEUTICALS LTD Avg $249.7K per shipment | 3 | $749.2K | 24.8% |
| 2 | SHIFAA PHARMA Avg $55.3K per shipment | 10 | $552.9K | 18.3% |
| 3 | TORRENT PHARMACEUTICALS LTD Avg $50.3K per shipment | 8 | $402.1K | 13.3% |
| 4 | TORRENT PHARMACEUTICALS LIMITED Avg $78.0K per shipment | 5 | $389.8K | 12.9% |
| 5 | GRACURE PHARMACEUTICALS LIMITED Avg $24.3K per shipment | 12 | $291.8K | 9.7% |
| 6 | TORRENT PHARMACEUTICALS LTD Avg $80.5K per shipment | 3 | $241.6K | 8.0% |
| 7 | BABA AGENCIES Avg $4.8K per shipment | 47 | $227.0K | 7.5% |
| 8 | MACLEODS PHARMACEUTICALS LIMITED Avg $32.4K per shipment | 3 | $97.2K | 3.2% |
| 9 | M/S MERCURY MEDICARE Avg $5.6K per shipment | 8 | $45.0K | 1.5% |
| 10 | SHIFAA PHARMA Avg $1.5K per shipment | 6 | $8.9K | 0.3% |
This table shows the top 10 of 18 Indian companies exporting celecoxib to Malaysia, ranked by total trade value. The listed exporters are: MACLEODS PHARMACEUTICALS LTD , SHIFAA PHARMA, TORRENT PHARMACEUTICALS LTD, TORRENT PHARMACEUTICALS LIMITED, GRACURE PHARMACEUTICALS LIMITED, TORRENT PHARMACEUTICALS LTD , BABA AGENCIES, MACLEODS PHARMACEUTICALS LIMITED, M/S MERCURY MEDICARE, SHIFAA PHARMA . MACLEODS PHARMACEUTICALS LTD is the dominant supplier with 3 shipments worth $749.2K USD, giving it a 25% market share. The top 3 suppliers together account for 56% of the total trade value on this route.
Showing top 10 of 18 total Indian exporters on the India to Malaysia Celecoxib export route.
Top 10 Celecoxib Importers in Malaysia
Showing top 10 of 21 known buyers in Malaysia receiving Celecoxib shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian celecoxib in Malaysia include DKSH MALAYSIA SDN BHD, SYNERRY SDN BHD , EFS LOGISTICS SDN BHD,, DKSH MALAYSIA SDN BHD , NILA JAMAL ENTERPRISE, among 21 total buyers. The largest importer is DKSH MALAYSIA SDN BHD, accounting for $782.2K USD across 12 shipments — representing 26% of all celecoxib imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | DKSH MALAYSIA SDN BHD | 12 | $782.2K | 25.9% |
| 2 | SYNERRY SDN BHD | 3 | $749.2K | 24.8% |
| 3 | EFS LOGISTICS SDN BHD, | 8 | $550.5K | 18.2% |
| 4 | DKSH MALAYSIA SDN BHD | 3 | $241.6K | 8.0% |
| 5 | NILA JAMAL ENTERPRISE | 45 | $226.3K | 7.5% |
| 6 | HEALOL PHARMACEUTICALS SDN BHD | 4 | $145.9K | 4.8% |
| 7 | SYNERRY SDN BHD | 3 | $97.2K | 3.2% |
| 8 | HEALOL PHARMACEUTICALS SDN.BHD | 4 | $73.4K | 2.4% |
| 9 | EFS LOGISTICS SDN BHD | 6 | $46.4K | 1.5% |
| 10 | HEALOL PHARMACETUICALS SDN.BHD. | 1 | $36.3K | 1.2% |
Showing top 10 of 21 Celecoxib importers in Malaysia on this route.
Top 10 Celecoxib Formulations Imported by Malaysia
Showing top 10 of 73 product formulations shipped on the India to Malaysia Celecoxib route, ranked by trade value
Malaysia imports a wide range of celecoxib formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — CELEBIB 200 (CELECOXIB CAPSULE 200 MG) 1 — accounts for $749.2K USD across 3 shipments. There are 73 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | CELEBIB 200 (CELECOXIB CAPSULE 200 MG) 1 | 3 | $749.2K | 24.8% |
| 2 | COBIX CAPS (CELECOXIB 200 MG) | 7 | $549.8K | 18.2% |
| 3 | OTHERS - TORCOXIB 200MG CAPSULES CELECOXIB 200MG 1 NOS = SIZE 3X10 CAPS | 2 | $214.2K | 7.1% |
| 4 | COBIX 200MG TAB (CELECOXIB CAPSULES) | 8 | $202.2K | 6.7% |
| 5 | OTHER-TORCOXIB 200 MG CAPSULES (CELECOXIB 200 MG) (QTY. 14976 X3X10 CAPSULES) | 1 | $119.8K | 4.0% |
| 6 | TORCOXIB 200MG CAPSULES (CELECOXIBCAPSULES 200MG) (NOS=3X10 CAPSULES ) | 1 | $110.8K | 3.7% |
| 7 | CELEBIB 200 (CELECOXIB CAPSULE 200MG) 10X10'S (15480 PAC)TBS | 3 | $97.2K | 3.2% |
| 8 | TORCOXIB 200MG CAPSULES (CELECOXIB 200MG) (NOS=3X10 CAPSULES)NOS | 1 | $92.2K | 3.0% |
| 9 | OTHER - TORCOXIB 200MG CAPSULES (CELECOXIB 200MG) (ACT QTY. 9216 X3X10 TAB) | 1 | $74.2K | 2.5% |
| 10 | TORCOXIB 200MG CAPSULES (CELECOXIB 200MG) (ACT. QTY. 8640 X 3 X 10 CAPSULES)NOS | 1 | $69.6K | 2.3% |
Showing top 10 of 73 Celecoxib formulations imported by Malaysia on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 67% sea for bulk, 16% air for urgent orders.
Top Ports of Origin
CHENNAI AIR CARGO ACC (INMAA4) handles the highest volume with 62 shipments. Transit time averages 24 days by sea.
Market Dynamics
India's celecoxib exports to Malaysia are driven primarily by a handful of large-scale manufacturers. MACLEODS PHARMACEUTICALS LTD with 3 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 18 active exporters signals a competitive but concentrated market — buyers in Malaysia benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — MACLEODS PHARMACEUTICALS LTD , SHIFAA PHARMA, TORRENT PHARMACEUTICALS LTD — together account for 56% of total trade value on this route. The average shipment value of $19.3K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as cobix caps (celecoxib 200 mg) and others - torcoxib 200mg capsules celecoxib 200mg 1 nos = size 3x10 caps, suggesting that buyers in Malaysia tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, DKSH MALAYSIA SDN BHD is the largest importer with 12 shipments worth $782.2K USD — representing 26% of all celecoxib imports from India on this route. A total of 21 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $3.0M
- Avg. Shipment
- $19.3K
- Suppliers
- 18
- Buyers
- 21
- Transit (Sea)
- ~24 days
- Annual Growth
- +25.4%
Other Celecoxib Routes
Unlock the Full India to Malaysia Celecoxib Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 157 shipments on this route.
Frequently Asked Questions — India to Malaysia Celecoxib Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Celecoxib to Malaysia?
The leading Indian exporters of Celecoxib to Malaysia are MACLEODS PHARMACEUTICALS LTD , SHIFAA PHARMA, TORRENT PHARMACEUTICALS LTD. MACLEODS PHARMACEUTICALS LTD holds the largest market share at approximately 25% of total trade value on this route.
Q What is the total value of Celecoxib exports from India to Malaysia?
India exports Celecoxib to Malaysia worth approximately $3.0M USD across 157 recorded shipments. The average value per shipment is $19.3K USD.
Q Which ports does India use to ship Celecoxib to Malaysia?
The most active port of origin is CHENNAI AIR CARGO ACC (INMAA4) with 62 shipments. Indian exporters primarily use a mix of sea and air freight for this route, with 67% of shipments going by sea and 16% by air.
Q How long does shipping take from India to Malaysia for Celecoxib?
The average transit time for Celecoxib shipments from India to Malaysia is approximately 24 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to Malaysia Celecoxib trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 25.4% with demand growth tracking at 21.4%. The route is ranked #20 among India's top Celecoxib export destinations globally.
Q How many suppliers are active on the India to Malaysia Celecoxib route?
There are currently 18 active Indian suppliers exporting Celecoxib to Malaysia. The market is moderately concentrated with MACLEODS PHARMACEUTICALS LTD accounting for 25% of total shipment value.
Q Who are the main importers of Celecoxib from India in Malaysia?
The leading importers of Indian Celecoxib in Malaysia include DKSH MALAYSIA SDN BHD, SYNERRY SDN BHD , EFS LOGISTICS SDN BHD,, DKSH MALAYSIA SDN BHD , NILA JAMAL ENTERPRISE. DKSH MALAYSIA SDN BHD is the largest buyer with 12 shipments worth $782.2K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Malaysia export trade corridor identified from Indian Customs (DGFT) records for Celecoxib.
- 2.Supplier/Buyer Matching: 18 Indian exporters and 21 importers in Malaysia matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 157 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
157 Verified Shipments
18 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists